Cytochrome P450 gene-based drug prescribing and factors impacting translation into routine clinical practice

Author： Wilke Russell A Musana A Kenneth Weber Wendell W

ISSN： 1741-0541

Source： Personalized Medicine, Vol.2, Iss.3, 2005-08, pp. : 213-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translation from clinical trials to routine practice: How to demonstrate community benefit

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 1-3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 449-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Structure and genetic mapping of the Cytochrome P450 gene (CYP1A5) in the turkey (Meleagris gallopavo)

Cytogenetic and Genome Research, Vol. 116, Iss. 1-2, 2007-02 ,pp. : 104-109

Karger

Access to resources Recommend Favorite

Structure, Genetic Mapping, and Function of the Cytochrome P450 3A37 Gene in the Turkey (Meleagris gallopavo)

Cytogenetic and Genome Research, Vol. 125, Iss. 1, 2009-07 ,pp. : 67-73

Karger

Access to resources Recommend Favorite

Pharmacogenetic testing in the face of unclear clinical efficacy: Lessons from cytochrome P450 2D6 for tamoxifen

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3703-3709

John Wiley & Sons Inc

Access to resources Recommend Favorite